JP2010509241A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010509241A5 JP2010509241A5 JP2009535502A JP2009535502A JP2010509241A5 JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5 JP 2009535502 A JP2009535502 A JP 2009535502A JP 2009535502 A JP2009535502 A JP 2009535502A JP 2010509241 A5 JP2010509241 A5 JP 2010509241A5
- Authority
- JP
- Japan
- Prior art keywords
- inhibition
- peptide
- nanoparticles
- combinations
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86466506P | 2006-11-07 | 2006-11-07 | |
| PCT/US2007/083772 WO2008058125A2 (en) | 2006-11-07 | 2007-11-06 | Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010509241A JP2010509241A (ja) | 2010-03-25 |
| JP2010509241A5 true JP2010509241A5 (https=) | 2010-12-09 |
Family
ID=39365311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009535502A Withdrawn JP2010509241A (ja) | 2006-11-07 | 2007-11-06 | 膜貫通ペプチドからなる自己凝集性ナノ粒子および抗癌剤の特異的腫瘍内送達のためのその利用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9326950B2 (https=) |
| EP (1) | EP2086521A2 (https=) |
| JP (1) | JP2010509241A (https=) |
| CN (1) | CN101610759A (https=) |
| AU (1) | AU2007316416A1 (https=) |
| CA (1) | CA2668638A1 (https=) |
| NZ (1) | NZ576769A (https=) |
| WO (1) | WO2008058125A2 (https=) |
| ZA (1) | ZA200903125B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2086521A2 (en) * | 2006-11-07 | 2009-08-12 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| WO2012162628A2 (en) | 2011-05-25 | 2012-11-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Lipopeptide inhibitors of ras oncoproteins |
| EP2911701A4 (en) | 2012-10-23 | 2016-06-08 | Univ Johns Hopkins | Novel self-assembling drug amphiphiles and methods for synthesis and application |
| ES2625024B1 (es) * | 2015-12-18 | 2018-05-10 | Consejo Superior De Investigaciones Cientificas | Material que comprende tectómeros de oligoglicina y nanohilos |
| US11246924B2 (en) | 2016-04-01 | 2022-02-15 | Duke University | Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform |
| WO2019018572A1 (en) * | 2017-07-18 | 2019-01-24 | Duke University | COMPOSITIONS AND METHODS COMPRISING SELF-ASSEMBLY PEPTIDE-POLYMER NANOFIBERS FOR SUBLINGUAL IMMUNIZATION |
| WO2026018050A1 (en) | 2024-07-14 | 2026-01-22 | Zare Zardini Hadi | Pistacia-derived bioactive peptides encapsulated in soy protein nanoparticles as an anticancer drug |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4121151B2 (ja) * | 1996-04-12 | 2008-07-23 | アメリカ合衆国 | 抗新生物薬および抗レトロウイルス薬として有用なアクリドンから誘導された化合物 |
| AU760208B2 (en) * | 1998-02-27 | 2003-05-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | G protein-coupled receptor antagonists |
| US7105488B1 (en) * | 1998-02-27 | 2006-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | G protein-coupled receptor antagonists |
| US7517849B1 (en) * | 1999-11-18 | 2009-04-14 | The United States Of America As Represented By The Secretary Of Health And Human Services | Inhibition of ABC transporters by transmembrane domain analogs |
| DE60100855T2 (de) * | 2000-03-07 | 2004-07-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung |
| CN1254234C (zh) | 2000-06-09 | 2006-05-03 | 莱古伦公司 | 质粒dna(lipogenestm)和含细胞核定位信号/促融合肽缀合物的治疗剂包封到定向脂质体复合体中 |
| WO2002062823A2 (en) * | 2001-02-02 | 2002-08-15 | Yale University | Peptides for facilitating composite receptor expression and translocation of macromolecules |
| WO2006010083A2 (en) * | 2004-07-08 | 2006-01-26 | Molecular Therapeutics, Inc. | Biodegradable nanoparticles |
| EP2086521A2 (en) * | 2006-11-07 | 2009-08-12 | Government of the United States of America, Represented by the Secretary, Department of Health and Human Services | Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
-
2007
- 2007-11-06 EP EP07868671A patent/EP2086521A2/en not_active Withdrawn
- 2007-11-06 NZ NZ576769A patent/NZ576769A/en not_active IP Right Cessation
- 2007-11-06 WO PCT/US2007/083772 patent/WO2008058125A2/en not_active Ceased
- 2007-11-06 CA CA002668638A patent/CA2668638A1/en not_active Abandoned
- 2007-11-06 AU AU2007316416A patent/AU2007316416A1/en not_active Abandoned
- 2007-11-06 US US12/513,950 patent/US9326950B2/en active Active
- 2007-11-06 CN CNA2007800459379A patent/CN101610759A/zh active Pending
- 2007-11-06 JP JP2009535502A patent/JP2010509241A/ja not_active Withdrawn
-
2009
- 2009-05-06 ZA ZA200903125A patent/ZA200903125B/xx unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sedighi et al. | Multifunctional self-assembled peptide hydrogels for biomedical applications | |
| Wang et al. | Recent advances in the fabrication, functionalization, and bioapplications of peptide hydrogels | |
| AU2024202093A1 (en) | Peptides and nanoparticles for intracellular delivery of mrna | |
| JP2010509241A5 (https=) | ||
| Tikhomirov et al. | Exosomes: from potential culprits to new therapeutic promise in the setting of cardiac fibrosis | |
| Zhao et al. | Recent advances in CXCL12/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy | |
| JP6881813B2 (ja) | 核酸ワクチン | |
| KR102714709B1 (ko) | 조건부 활성 폴리펩티드 | |
| Liang et al. | Enzyme-assisted peptide folding, assembly and anti-cancer properties | |
| Zhang et al. | Instructive design of triblock peptide amphiphiles for structurally complex micelle fabrication | |
| CN111132999A (zh) | 支架蛋白 | |
| KR20140103914A (ko) | 운반물 경피 전달을 포함하는 타켓 전달용 다공성 나노입자-지지 지질 이중층(프로토셀) 및 그 방법 | |
| JP2014500867A (ja) | 皮膚浸透性および細胞侵入性（ｓｐａｃｅ）ペプチドとその使用法 | |
| AU2019210188B2 (en) | Altering inflammatory states of immune cells in vivo by modulating cellular activation states | |
| JP6175055B2 (ja) | ウイルス感染増強特性を有するペプチドおよびその使用 | |
| Du et al. | Targeting macrophage polarization for reinstating homeostasis following tissue damage | |
| CN111787912A (zh) | 用于核酸分子递送的纳米颗粒-水凝胶复合物 | |
| KR101581926B1 (ko) | 자기조립 펩타이드 나노캡슐 및 이를 포함하는 약물전달담체 | |
| JP2013510165A (ja) | 活性産生送達分子 | |
| Neri et al. | Tuning the Loading and Release Properties of MicroRNA-Silencing Porous Silicon Nanoparticles by Using Chemically Diverse Peptide Nucleic Acid Payloads | |
| CN118201625A9 (zh) | 微藻胞外囊泡、其制备和用途 | |
| Yang et al. | Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease | |
| Scognamiglio et al. | Dancing with Nucleobases: Unveiling the Self-Assembly Properties of DNA and RNA Base-Containing Molecules for Gel Formation | |
| KR101336552B1 (ko) | 전립선암 특이적 ｓｉＲＮＡ 전달체 | |
| Wang et al. | Role of the Na+/K+-ATPase beta-subunit in peptide-mediated transdermal drug delivery |